Updated Jul 16, 2026
Jallal Bahija has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $371K.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-15 | ELV | Elevance Health, Inc. | A — Grant or award | 563 | $0.00 | |
| 2026-02-19 | IMCR | Immunocore Holdings plc | S — Open-market sale | 11.5K | $32.35 | $371K |
| 2026-02-19 | IMCR | Immunocore Holdings plc | M — Option exercise | 23.8K | $0.00 | |
| 2025-05-14 | ELV | Elevance Health, Inc. | A — Grant or award | 601 | $0.00 |
Jallal Bahija is a corporate insider — currently tracked as Director of Elevance Health, Inc. (ELV). InsiderAlpha tracks every SEC Form 4 filing in real time.
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 1 open-market sales ($371K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Jallal Bahija profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.